Oncoplastic partial breast reconstruction improves patient satisfaction and aesthetic outcome for central breast tumours.


Journal

ANZ journal of surgery
ISSN: 1445-2197
Titre abrégé: ANZ J Surg
Pays: Australia
ID NLM: 101086634

Informations de publication

Date de publication:
05 2019
Historique:
received: 21 08 2018
revised: 15 12 2018
accepted: 21 12 2018
pubmed: 22 3 2019
medline: 9 6 2020
entrez: 22 3 2019
Statut: ppublish

Résumé

Patients with centrally located tumours involving the nipple-areolar complex (NAC) who undergo breast-conserving treatment (BCT) are at high risk for breast deformity and asymmetry. Immediate oncoplastic breast reconstruction (OBR) can have a favourable impact on surgical outcome. We retrospectively compared aesthetic outcomes and patient satisfaction among women treated with NAC lumpectomy and immediate OBR with patients treated with BCT alone. Aesthetic outcome was evaluated by independent observers, and patient satisfaction was assessed by the BREAST-Q questionnaire. A total of 24 patients were studied, 12 in each group. Demographics and oncological staging were similar in both groups, apart from mean age, hypertension and tumour size/lumpectomy weight. Patients in the OBR group had higher scores for aesthetic outcome and a higher degree of patient satisfaction from the surgical outcome compared to the patients in the BCT-alone group. The immediate OBR approach in the treatment of centrally located tumours with NAC resection has clear advantages over BCT alone. This approach should be considered for and offered to suitable patients.

Sections du résumé

BACKGROUND
Patients with centrally located tumours involving the nipple-areolar complex (NAC) who undergo breast-conserving treatment (BCT) are at high risk for breast deformity and asymmetry. Immediate oncoplastic breast reconstruction (OBR) can have a favourable impact on surgical outcome.
METHODS
We retrospectively compared aesthetic outcomes and patient satisfaction among women treated with NAC lumpectomy and immediate OBR with patients treated with BCT alone. Aesthetic outcome was evaluated by independent observers, and patient satisfaction was assessed by the BREAST-Q questionnaire.
RESULTS
A total of 24 patients were studied, 12 in each group. Demographics and oncological staging were similar in both groups, apart from mean age, hypertension and tumour size/lumpectomy weight. Patients in the OBR group had higher scores for aesthetic outcome and a higher degree of patient satisfaction from the surgical outcome compared to the patients in the BCT-alone group.
CONCLUSIONS
The immediate OBR approach in the treatment of centrally located tumours with NAC resection has clear advantages over BCT alone. This approach should be considered for and offered to suitable patients.

Identifiants

pubmed: 30895710
doi: 10.1111/ans.15078
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

536-540

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 Royal Australasian College of Surgeons.

Auteurs

Shirley Shechter (S)

Department of Plastic and Reconstructive Surgery, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.

Or Friedman (O)

Department of Plastic and Reconstructive Surgery, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.

Amir Inbal (A)

Department of Plastic and Reconstructive Surgery, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.

Ehud Arad (E)

Department of Plastic and Reconstructive Surgery, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.

Tehillah Menes (T)

The Breast Health Center, Tel-Aviv Sourasky Medical Center, Affiliated with the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Daphna Barsuk (D)

General Surgery, Assuta Medical Center, Tel Aviv, Israel.

Eyal Gur (E)

Department of Plastic and Reconstructive Surgery, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.

Yoav Barnea (Y)

Department of Plastic and Reconstructive Surgery, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH